Subscribe
Logo smallSearch
banner

Irritable bowel syndrome drug halted from marketing

MedExpress Team

Medexpress

Published June 28, 2023 09:00

Irritable bowel syndrome drug halted from marketing - Header image
Źródło: GIF
What was the reason for the decision?

The Chief Pharmaceutical Inspector has decided to suspend nationwide marketing of the drug Mebelin (Mebeverini hydrochloridum), modified-release capsules, hard, 200 mg, pack of 30 capsules GTIN No. 05909991425289, pack of 60 capsules GTIN No. 05909991425296...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also